Preclinical Evaluation of Stx-0712, a CCR2 Cytotoxicity Targeting Chimera (CCR2-CyTAC) for the Treatment of Chronic Myelomonocytic LeukemiaBrandon J. Turunen, Mrinal M. Patnaik, Matthew Smith et al.|Blood|2024Cited by 1